Jatenzo Capsule, Liquid Filled
NDC Package 69087-237-28
Package Information
Jatenzo (testosterone undecanoate) capsules is a medication used in men who do not make enough of a natural substance called testosterone. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Tolmar Inc., this product is identified by NDC 69087-237 and is authorized under FDA application NDA206089.
Identification & Billing
- RxCUI: 2121766 - testosterone undecanoate 158 MG Oral Capsule
- RxCUI: 2121768 - testosterone undecanoate 198 MG Oral Capsule
- RxCUI: 2121770 - testosterone undecanoate 237 MG Oral Capsule
- RxCUI: 2121776 - JATENZO 237 MG Oral Capsule
- RxCUI: 2121776 - testosterone undecanoate 237 MG Oral Capsule [Jatenzo]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69087 - Tolmar Inc.
- 69087-237 - Jatenzo
- 69087-237-28 - 48 BOTTLE, PLASTIC in 1 BOX / 28 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
- 69087-237 - Jatenzo
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (69087-237). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69087-237-28 identifies a specific commercial package of 48 bottle, plastic in 1 box / 28 capsule, liquid filled in 1 bottle, plastic of Jatenzo, a human prescription drug labeled by Tolmar Inc.. This capsule, liquid filled is formulated for oral use and contains testosterone undecanoate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Tolmar Inc. on August 01, 2019. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used in men who do not make enough of a natural substance called testosterone. Testosterone belongs to a class of drugs known as androgens. Testosterone helps the body to develop and maintain male sexual characteristics (masculinity), such as a deep voice and body hair. It also helps to maintain muscle and prevent bone loss, and is necessary for natural sexual ability/desire. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. This product should not be used in women.
How is this Tolmar Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69087023728. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.